A Phase 1b Study of ZN-c3 in Chinese Subjects

NCT04972422 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: ZN-c3

Sponsor

Zentera Therapeutics HK Limited